About Transmembrane and ubiquitin-like domain-containing protein 2
Transmembrane and ubiquitin-like domain-containing protein 2 (TMUB2) is a protein
from Homo sapiens identified by UniProt accession
Q71RG4, 321 residues long.
MolForge cross-references it against 0 known binders and
39 disease associations.
Target properties
| Protein name | Transmembrane and ubiquitin-like domain-containing protein 2 |
| UniProt accession | Q71RG4 |
| Gene | TMUB2 |
| Organism | Homo sapiens |
| Length | 321 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (39)
Diseases linked to this target (Open Targets).
- mean platelet volume · score 0.13
- body fat distribution · score 0.11
- sex hormone-binding globulin measurement · score 0.10
- body weight · score 0.09
- body mass index · score 0.09
- calcium measurement · score 0.09
- HbA1c measurement · score 0.08
- appendicular lean mass · score 0.08
- hematocrit · score 0.07
- visceral adipose tissue measurement · score 0.07
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q71RG4-F1 | alphafold | PREDICTED | 62.07 | — |
Amino-acid sequence (321 residues)
MISRHLQNNL MSVDPASSQA MELSDVTLIE GVGNEVMVVA GVVVLILALV LAWLSTYVAD SGSNQLLGAI VSAGDTSVLH LGHVDHLVAG QGNPEPTELP HPSEGNDEKA EEAGEGRGDS TGEAGAGGGV EPSLEHLLDI QGLPKRQAGA GSSSPEAPLR SEDSTCLPPS PGLITVRLKF LNDTEELAVA RPEDTVGALK SKYFPGQESQ MKLIYQGRLL QDPARTLRSL NITDNCVIHC HRSPPGSAVP GPSASLAPSA TEPPSLGVNV GSLMVPVFVV LLGVVWYFRI NYRQFFTAPA TVSLVGVTVF FSFLVFGMYG R
Explore Transmembrane and ubiquitin-like domain-containing protein 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets